Human PRKD1 adenoviral particles

Protein kinase D1 (PRKD1), also known as PKD1, is a serine/threonine kinase that belongs to the protein kinase D (PKD) family. It plays a key role in a variety of cellular processes, including signal transduction, cell proliferation, migration, apoptosis, and immune responses. PRKD1 is activated by diacylglycerol (DAG) and phosphorylation events downstream of G protein-coupled receptors (GPCRs) and growth factor receptors. Dysregulation of PRKD1 has been implicated in a variety of diseases, such as cancer, cardiovascular disease, and inflammation. It is able to regulate key pathways such as NF-κB and MAPK. Given its broad functional relevance, PRKD1 is an important target for research aimed at understanding disease mechanisms and developing therapeutic interventions. Human PRKD1 adenoviral particles are an advanced molecular tool designed to efficiently deliver genes into mammalian cells. These recombinant adenoviruses carry the PRKD1 gene and can be used for overexpression or functional studies of PRKD1 in vitro and in vivo. Adenoviral vectors are particularly advantageous due to their high transduction efficiency, broad tropism, and ability to infect both dividing and non-dividing cells. These viral particles are specially designed with safety features such as replication defectiveness to minimize the risk of uncontrolled spread of the virus. The researchers used human PRKD1 adenoviral particles to study the role of PRKD1 in cell signaling, disease progression and potential therapeutic applications.